RE245, or RE-245, is a non-hallucinogenic psychoplastogen which is under development for the treatment of psychiatric disorders. It is taken orally. The drug acts as a serotonin receptor modulator, including of the serotonin 5-HT2A receptor, and is said to have psychoplastogenic effects.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.